COH Share Price

Open 159.92 Change Price %
High 160.00 1 Day -1.69 -1.06
Low 157.08 1 Week 2.87 1.85
Close 157.75 1 Month 15.64 11.01
Volume 213125 1 Year 36.73 30.35
52 Week High 161.14
52 Week Low 112.51
COH Important Levels
Resistance 2 160.46
Resistance 1 159.34
Pivot 158.28
Support 1 156.16
Support 2 155.04
ASX Australia Most Active Stocks
DUE 3.02 1.00%
DUE 3.02 1.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
TLS 4.32 -0.23%
TLS 4.32 -0.23%
TLS 4.32 -0.23%
DJS 3.99 0.00%
DJS 3.99 0.00%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
GBP 0.04 100.00%
GBP 0.04 100.00%
POH 0.02 100.00%
BNV 0.03 50.00%
PVE 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
AHN 0.03 50.00%
More..
ASX Australia Top Losers Stocks
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
GDY 0.01 -50.00%
ANO 0.02 -33.33%
ANO 0.02 -33.33%
ANO 0.02 -33.33%
ICN 0.02 -33.33%
More..

Cochlear Ltd (ASX: COH)

COH Technical Analysis 5
As on 22nd Jun 2017 COH Share Price closed @ 157.75 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 133.52 & Strong Buy for SHORT-TERM with Stoploss of 144.79 we also expect STOCK to react on Following IMPORTANT LEVELS.
COH Target for June
1st Target up-side 152.35
2nd Target up-side 156.39
3rd Target up-side 160.43
1st Target down-side 140.83
2nd Target down-side 136.79
3rd Target down-side 132.75
COH Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.cochlear.com
COH Address
COH
1 University Avenue
Macquarie University, NSW 2109
Australia
Phone: 61 2 9428 6555
Fax: 61 2 9428 6352
COH Latest News
Interactive Technical Analysis Chart Cochlear Ltd ( COH ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Cochlear Ltd
COH Business Profile
Cochlear Limited provides implantable hearing solutions. It offers the Cochlear Nucleus range of cochlear implant systems; Baha bone conduction implants for treating conductive hearing loss, mixed hearing loss, and single-sided deafness; bone anchored prosthetics, such as the Cochlear Vistafix bone-anchored facial prosthetic solution to enhance the attachment and cosmetic outcome of facial prostheses; and support services. The company provides its products directly, as well as through distributors and agents in the United States, Canada, and Latin America; Europe, the Middle East, and Africa; and Australasia and Asia. Cochlear Limited is headquartered in Macquarie University, Australia.